ClinicalTrials.gg
CompletedNCT03374696Updated Dec 15, 2017

Theater in School Sex Education - a Randomized Controlled Study

An interventional study of SAFETY and Standard education in Attitude, Sexual Behavior and Condom Use, sponsored by Örebro University, Sweden. Completed. Open to participants aged 13 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-12-15.

Primary conditionSexual BehaviorRegistry: BehaviorReclassifiedWhy we changed it
Registry
Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sexual Behavior
Why
  1. The study's listed conditions name Sexual Behavior, a narrower term within Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Örebro University, Sweden · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Dec 2016, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
826
Allocation
Randomized
Ages
13 Years to 15 Years
Sex
All
01

Study summary

The study evaluated if interactive theater in school sex education affects student knowledge, attitudes and behavior regarding condom use. The intervention group got a play, value exercises, chlamydia games, condom school and interactive replay with professional actors and staff from a youth guidance center. The control group got standard sex education from school staff, based on the education guidelines of the Swedish National Agency for Education.

Read the detailed description

The spread of chlamydia indicates that current preventive work with condoms is insufficient. Research shows that reasons behind increased chlamydia include youths taking more sexual risks, due to altered attitudes and sexual behaviors. Since only condoms protect against both sexually transmitted infections (STIs) and unwanted pregnancy, the goal of the World Health Organization (WHO) chlamydia prevention program is to increase condom use. Research suggests that school is the most important arena for sex education, reaching all youths early in life, when many values on sex and relationships are instilled. International studies on theater in sex education indicate effects like increased knowledge on the topic, and partially changed attitudes and behaviors among youths. Furthermore, several studies show that youths feel theater is a good method for sex education and a supplement to standard education.

02

Conditions studied

  • Attitude
  • Sexual Behavior
  • Condom Use
  • Prevention
  • Chlamydia Infections
  • Safe Sex

Browse trials for

Keywords

  • Chlamydia infections
  • condoms
  • theater,
  • sex education
03

In context

Sexual Behavior Reclassified

224 studies on the registry are indexed under Sexual Behavior; 30 are open to participants now.

This study's enrollment of 826 is above the median of 264 across 179 interventional studies indexed under Sexual Behavior.

Browse Sexual Behavior studies →

Lead sponsor

Örebro University, Sweden is the lead sponsor of 86 studies on the registry; 14 are open to participants now.

Compared within Sexual Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
13 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • students in eighth grade
  • could read and understand Swedish

Exclusion criteria

Exclusion Criteria:

  • students in special education.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
826 participants (actual)

Study arms

  • Experimental
    Intervention group

    The intervention SAFETY was performed in school facilities by professional actors and staff from the municipality's youth guidance center within the county. The actors first enacted a play portraying youths and problems with condom use. Next, a value exercise was held by the youth guidance center staff. The class continued with chlamydia games held by the youth guidance center staff, providing information on symptoms, protection, how to get tested, treatment and consequences. The youth guidance center staff and the actors, playing students, then held a condom school. Lastly, the students came up with new endings to the play. All replays were enacted and the students gave feedback on the new endings. The class ended with condoms being handed out.

    Behavioral: SAFETY

  • Active comparator
    Control group

    The intervention in the control group contained standard education from school staff, based on the sex education guidelines of the Swedish National Agency for Education. Students got education on human sexuality, reproduction, menstruation, love, sex, pregnancy and how STIs and unwanted pregnancy are prevented.

    Behavioral: Standard education

Interventions

  • BehavioralSAFETY
  • BehavioralStandard education
06

What researchers measure

Primary outcomes

  1. - Knowledge of condom use and chlamydia. - Attitudes toward condom use. - Behavior relating to condom use.

    Web-based surveys contained questions about * knowledge of condom use and chlamydia (7 questions) * attitudes toward condom use (5 questions) * behavior relating to condom use (6 questions)

    Time frame: One month.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data for all primary outcome measures will be made available on request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2016 to primary completion in Mar 2017, 3 months.

Of 106 non-industry interventional studies with no phase under Sexual Behavior, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's 3 months is below that.

Counting every sponsor, half of 107 studies reached it within 23 months; a quarter within 11 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2017
First posted
Dec 15, 2017
StartActual
Dec 1, 2016
Primary completionActual
Mar 31, 2017
CompletionActual
Mar 31, 2017
Last update
Dec 15, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03374696
Lead sponsor
Örebro University, Sweden
Responsible party
Annsofie Adolfsson (Associate Professor, Örebro University, Sweden) — Principal investigator
First posted
Dec 15, 2017
Start date
Dec 1, 2016
Primary completion
Mar 31, 2017
Completion
Mar 31, 2017
Last update
Dec 15, 2017

Study contacts

Annsofie Adolfsson, Med Dr
principal investigator · Orebro University, School of Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion